Rexahn: Rodman & Renshaw Global Investment Conference (Rexahn Pharmaceuticals, Inc, Rodman and Renshaw 18th Annual Global Investment Conference 2016) - Sep 18, 2016 - Anticipated presentation of P1b/P2a trial (NCT02030067) in stage 1 pancreatic cancer at ESMO (Oct 7-11, 2016)
Anticipated P1/2 data • Oncology
|